Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» January 2011
January 2011
5 Drugmakers Headed Back to the Drawing Board
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
Oops! Arena’s CEO Neglects to Mention Diet Drug Causes Cancer in Rats
Oops! Arena’s CEO Neglects to Mention Diet Drug Causes Cancer in Rats
BNET Pharma
cancer
obesity
Arena Pharmaceuticals
Lorqess
Jack Lief
Drug Approved! Now Who's Going to Launch It?
Drug Approved! Now Who's Going to Launch It?
Motley Fool
Depomed
shingles
postherpetic neuralgia
Gralise
Merck
Abbott Laboratories
GSK
Pfizer
Earnings Preview: Pfizer
Earnings Preview: Pfizer
Seeking Alpha
earnings
Pfizer
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
Investopedia
earnings
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
MannKind
Novartis
Vivus
Is Johnson & Johnson the Perfect Stock?
Is Johnson & Johnson the Perfect Stock?
Motley Fool
JNJ
Sanofi, Genzyme Agree on Merger Outline
Sanofi, Genzyme Agree on Merger Outline
TheStreet.com
M&A
Genzyme
Sanofi
Novartis Says FDA Approves Menveo in Kids, Not Infants
Novartis Says FDA Approves Menveo in Kids, Not Infants
Bloomberg
FDA
Novartis
vaccines
Menveo
meningococcal disease
What Gralise Approval Means for Depomed
What Gralise Approval Means for Depomed
Seeking Alpha
Depomed
Gralise
gabapentin
postherpetic neuralgia
Orexigen shares jump ahead of FDA decision
Orexigen shares jump ahead of FDA decision
Marketwatch
FDA
Contrave
Orexigen
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »